Hereditary Testing Market

Hereditary Testing Market Size, Share, Growth Analysis, By Disease Type(Hereditary Cancer Testing, Lung Cancer, Breast Cancer, Colorectal Cancer), By Technology(Cytogenetic, Biochemical, Molecular Testing), By Regional(North America, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35D2041 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Hereditary Testing Market Insights

Market Overview:

The global market for hereditary testing was valued at USD 6.1 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. The market growth is primarily attributed to the expanding reproductive genetic health sector. Companies such as Natera have reported an increase in test volumes for women's health genetic testing for inherited conditions, indicating a growing acceptance of hereditary tests among the population. This trend is expected to drive revenue growth in the market.

Hereditary Testing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Services by segment aggregation, the contribution of the Health Care Services in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Hereditary Testing was estimated to be valued at US$ XX Mn in 2021.

The Hereditary Testing Market is estimated to grow at a CAGR of XX% by 2028.

The Hereditary Testing Market is segmented on the basis of Disease Type, Technology, Regional.

Based on region, the Hereditary Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Hereditary Testing Market are Myriad Genetics, Inc., Invitae Corporation, Illumina, Inc., Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, CooperSurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience, Sophia Genetics, Fulgent Genetics, Inc., MedGenome.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Hereditary Testing Market

Report ID: UCMIG35D2041

$5,300
BUY NOW GET FREE SAMPLE